Biohaven (BHVN)
Develops prioritized drug programs in epilepsy, immunology, and obesity.
$14.85
After hours−0.02 (−0.13%)
At close$14.87(+4.57%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
in 48 days
EPS estimate
−$0.61
Revenue estimate
$70.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$1.85−$2.17−$1.94−$1.64−$1.21−$0.88−$0.91Pending
Estimate−$1.56−$1.67−$1.94−$1.91−$1.22−$0.86−$0.76−$0.61
Surprise−18.6%−29.9%0.0%+14.1%+0.8%−2.3%−19.6%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate——$412.6K$375.1K$400.0K$267.4K$490.5K$70.0M
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.76 | — | — |
| Sep 2028 | −$0.81 | — | — |
| Jun 2028 | −$0.83 | — | — |
| Mar 2028 | −$0.85 | — | — |
| Dec 2027 | −$0.59 | — | — |
| Sep 2027 | −$0.65 | — | — |
| Jun 2027 | −$0.71 | — | — |
| Mar 2027 | −$0.66 | — | — |
| Dec 2026 | −$0.38 | — | — |
| Nov 2026 | −$0.61 | — | — |
| Aug 2026 | −$0.76 | −$0.91 | −19.6% |
| May 2026 | −$0.86 | −$0.88 | −2.3% |
| Mar 2026 | −$1.22 | −$1.21 | +0.8% |
| Nov 2025 | −$1.91 | −$1.64 | +14.1% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Jul 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| Jun 2017 | |||
| May 2017 | — | — | — |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.76 | — | — | $14.5M | — | — | — |
| Sep 2028 | −$0.81 | — | — | $7.2M | — | — | — |
| Jun 2028 | −$0.83 | — | — | $2.9M | — | — | — |
| Mar 2028 | −$0.85 | — | — | $0 | — | — | — |
| Dec 2027 | −$0.59 | — | — | $13.0M | — | — | — |
| Sep 2027 | −$0.65 | — | — | $34.5M | — | — | — |
| Jun 2027 | −$0.71 | — | — | $4.0M | — | — | — |
| Mar 2027 | −$0.66 | — | — | $1.2M | — | — | — |
| Dec 2026 | −$0.38 | — | — | $38.9M | — | — | — |
| Nov 9, 2026 | −$0.61 | — | — | $70.0M | — | — | — |
| Aug 10, 2026 | −$0.76 | −$0.91 | −19.6% | $490.5K | — | — | −0.3% |
| May 4, 2026 | −$0.86 | −$0.88 | −2.3% | $267.4K | — | — | +5.3% |
| Mar 2, 2026 | −$1.22 | −$1.21 | +0.8% | $400.0K | — | — | −9.7% |
| Nov 10, 2025 | −$1.91 | −$1.64 | +14.1% | $375.1K | — | — | −5.7% |
| Aug 11, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 3, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Feb 29, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Jul 31, 2023 | |||||||
| May 12, 2023 | |||||||
| Mar 23, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 5, 2022 | |||||||
| May 10, 2022 | |||||||
| Feb 25, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 1, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 25, 2020 | |||||||
| Nov 1, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 7, 2019 | |||||||
| Feb 28, 2019 | |||||||
| Nov 14, 2018 | |||||||
| Aug 14, 2018 | |||||||
| May 15, 2018 | |||||||
| Mar 6, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Aug 14, 2017 | |||||||
| Jun 16, 2017 | |||||||
| May 5, 2017 | — | — | — | — | — | — | — |